Middle ear effusion in patients with sinonasal cancer treated by surgery with or without radiotherapy.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 23348873.
- Also identified by DOI 10.1177/0194599812474798.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To identify the prevalence and risk factors of eustachian tube dysfunction after surgery for sinonasal cancer by observing the occurrence of middle ear effusion. Historical cohort study. Academic university hospital. Clinical records of 112 patients surgically treated for sinonasal cancer over a 16-year period were evaluated. Initial bivariate analysis was followed by a multivariate logistic regression model. The best model included 2 variables: posterior extension of surgical resection (nasopharynx, soft palate, eustachian tube, pterygomaxillary fossa, parapharyngeal space) with an odds ratio of 5.662 (95% confidence interval [CI], 1.877-9.447) and postoperative radiotherapy with an odds ratio of 8.691 (95% CI, 4.187-13.194). Despite the limited number of patients, the study gives a prediction of middle ear effusion based on 2 well-defined factors: surgical resection of anatomic structures involved in tubal function and adjuvant radiotherapy.
Medical subject headings
- Eustachian Tube
- Nose Neoplasms
- Otitis Media with Effusion
- Otorhinolaryngologic Surgical Procedures
- Radiotherapy, Adjuvant